logo
AI Icon𝛼SK or Search
ENTITY
CANbridge Pharmaceuticals

CANbridge Pharmaceuticals (1228 HK)

8
Analysis
Health Care • China
CANbridge Pharmaceuticals is a global biopharmaceutical company dedicated to the research, development, and commercialization of transformative therapies for rare diseases and oncology. The company offers approved drugs such as Hunterase for Hunter syndrome and Livmarli for Alagille syndrome, and is developing a pipeline of gene therapies and other assets. It was founded in 2012 and is headquartered in Suzhou, China.
more
Company Event • 29 Mar 2027 12:30 • Upcoming
Add To Calendar

H2 2026

Company Event • 28 Aug 2026 17:30 • Upcoming
Add To Calendar

H1 2026

Company Event • 30 Mar 2026 12:30 • Upcoming
Add To Calendar

H2 2025

Company Event • 31 Aug 2025 12:30 • Upcoming
Add To Calendar

H1 2025

Company Event • 31 Mar 2025 20:50 • Upcoming
Add To Calendar

H2 2024

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x